Kangpu Biopharmaceuticals

Company Drug

Kangpu Biopharmaceuticals Receives NMPA Approval for KPG-818 Phase IIb Study in SLE

Fineline Cube Apr 29, 2025

China-based Kangpu Biopharmaceuticals, Ltd announced that it has received approval from the National Medical Products...

Company Deals

Kangpu Biopharmaceuticals Secures Series B Funding to Advance Molecular Glue Therapies

Fineline Cube Aug 30, 2023

Shanghai-based Kangpu Biopharmaceuticals, Ltd has reportedly raised close to RMB 100 million (USD 13.8 million)...

Company Drug

Kangpu Biopharmaceuticals Begins Phase IIa Trial of KPG-818 for Systemic Lupus Erythematosus

Fineline Cube Jun 13, 2022

Shanghai-based Kangpu Biopharmaceuticals, Ltd has announced the first patient dosing in a multicenter, randomized, double-blind,...

Company Drug

Sino Biopharm’s TQA3605 Meets Endpoint in Hepatitis B Phase II Trial

Company Drug

J&J Darzalex Faspro Gets FDA Nod for NDMM D-VRd Regimen

Company Drug

Roche CT-388 Obesity Drug Shows 22.5% Weight Loss in Phase II Trial

Policy / Regulatory

FDA Removes Suicide Warnings from GLP‑1 Drugs After Investigation Finds No Causal Link